SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001193125-14-150761
Filing Date
2014-04-21
Accepted
2014-04-21 16:12:06
Documents
2
Group Members
JONATHAN A. FLINTPOLARIS VENTURE MANAGEMENT CO. V, L.L.C.POLARIS VENTURE PARTNERS ENTREPRENEURS' FUND V, L.P.POLARIS VENTURE PARTNERS FOUNDERS' FUND V, L.P.POLARIS VENTURE PARTNERS SPECIAL FOUNDERS' FUND V, L.P.TERRANCE G. MCGUIRE

Document Format Files

Seq Description Document Type Size
1 SC 13D d715449dsc13d.htm SC 13D 135450
2 EX-A d715449dex99a.htm EX-99.A 9223
  Complete submission text file 0001193125-14-150761.txt   146623
Mailing Address 840 MEMORIAL DRIVE 5TH FLOOR Cambridge MA 02139
Business Address 840 MEMORIAL DRIVE 5TH FLOOR Cambridge MA 02139 617-551-9600
Cerulean Pharma Inc. (Subject) CIK: 0001401914 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-88094 | Film No.: 14774004
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1000 WINTER STREET SUITE 3350 WALTHAM MA 02451
Business Address 1000 WINTER STREET SUITE 3350 WALTHAM MA 02451 781-290-0770
Polaris Venture Partners V, L.P. (Filed by) CIK: 0001439590 (see all company filings)

IRS No.: 204234825 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D